Cargando…

Non-Invasive Monitoring of Stromal Biophysics with Targeted Depletion of Hyaluronan in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDA) is characterized by a pronounced fibroinflammatory stromal reaction consisting of inordinate levels of hyaluronan (HA), collagen, immune cells, and activated fibroblasts that work in concert to generate a robust physical barrier to the perfusion and diffusion o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maloney, Ezekiel, DuFort, Christopher C., Provenzano, Paolo P., Farr, Navid, Carlson, Markus A., Vohra, Ravneet, Park, Joshua, Hingorani, Sunil R., Lee, Donghoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627077/ https://www.ncbi.nlm.nih.gov/pubmed/31167451 http://dx.doi.org/10.3390/cancers11060772

Ejemplares similares

Non-Invasive Monitoring of Increased Fibrotic Tissue and Hyaluronan Deposition in the Tumor Microenvironment in the Advanced Stages of Pancreatic Ductal Adenocarcinoma
por: Vohra, Ravneet, et al.
Publicado: (2022)

Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer
por: Provenzano, P P, et al.
Publicado: (2013)

Magnetic resonance imaging biomarkers for pulsed focused ultrasound treatment of pancreatic ductal adenocarcinoma
por: Maloney, Ezekiel, et al.
Publicado: (2020)

Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma
por: Lintern, Nicole, et al.
Publicado: (2023)

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
por: Sato, Norihiro, et al.
Publicado: (2016)

Stromal architecture directs early dissemination in pancreatic ductal adenocarcinoma
por: Ray, Arja, et al.
Publicado: (2022)

Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma
por: Cheng, Xiao-Bo, et al.
Publicado: (2013)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
por: Gebauer, Florian, et al.
Publicado: (2017)

Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma
por: Kudo, Yuzan, et al.
Publicado: (2019)

Prognostic and functional role of hyaluronan-binding protein 1 in pancreatic ductal adenocarcinoma
por: Adachi, Yasuhiro, et al.
Publicado: (2022)

The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma
por: Kudo, Daisuke, et al.
Publicado: (2017)

Hyaluronan Dermal Fillers: Efforts Towards a Wider Biophysical Characterization and the Correlation of the Biophysical Parameters to the Clinical Outcome
por: La Gatta, Annalisa, et al.
Publicado: (2020)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019)

Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma
por: Sperb, Nadine, et al.
Publicado: (2020)

B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
por: Minici, Claudia, et al.
Publicado: (2020)

Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal Adenocarcinoma
por: Sato, Daisuke, et al.
Publicado: (2016)

Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma
por: Mascharak, Shamik, et al.
Publicado: (2023)

Hyaluronan-based hydrogels as dermal fillers: The biophysical properties that translate into a “volumetric” effect
por: La Gatta, Annalisa, et al.
Publicado: (2019)

Hyaluronan and RHAMM in Wound Repair and the “Cancerization” of Stromal Tissues
por: Tolg, Cornelia, et al.
Publicado: (2014)

BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages
por: Rosati, Alessandra, et al.
Publicado: (2015)

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance
por: Vizio, Barbara, et al.
Publicado: (2018)

Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma
por: Suzuki, Yukie, et al.
Publicado: (2020)

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Goulart, Michelle R., et al.
Publicado: (2021)

Dielectric Characterization and Separation Optimization of Infiltrating Ductal Adenocarcinoma via Insulator-Dielectrophoresis
por: Adekanmbi, Ezekiel O., et al.
Publicado: (2020)

Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy
por: Shepard, H. Michael
Publicado: (2015)

Protocol to culture and image pancreatic ductal adenocarcinoma tumor slices to study T cell migration
por: Rodríguez-Merced, Nelson J., et al.
Publicado: (2023)

Targeting ErbB3-mediated stromal–epithelial interactions in pancreatic ductal adenocarcinoma
por: Liles, J S, et al.
Publicado: (2011)

A Speculative Role for Stromal Gastrin Signaling in Development and Dissemination of Pancreatic Ductal Adenocarcinoma
por: Matters, Gail L, et al.
Publicado: (2013)

Non-invasive tracking of disease progression in young dystrophic muscles using multi-parametric MRI at 14T
por: Park, Joshua S., et al.
Publicado: (2018)

Sarcomatoid Carcinoma of the Prostate: Ductal Adenocarcinoma and Stromal Sarcoma-Like Appearance: A Rare Association
por: Parada, David, et al.
Publicado: (2011)

High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
por: Steins, Anne, et al.
Publicado: (2020)

The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells
por: Kung, Pin-Jui, et al.
Publicado: (2021)

Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer
por: Koltai, Tomas, et al.
Publicado: (2021)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2023)

Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection
por: Drifka, Cole R., et al.
Publicado: (2016)

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
por: Van Cutsem, Eric, et al.
Publicado: (2020)

Anticancer Effects of Sinulariolide-Conjugated Hyaluronan Nanoparticles on Lung Adenocarcinoma Cells
por: Hsiao, Kuan Yin, et al.
Publicado: (2016)

Developing Fluorescent Hyaluronan Analogs for Hyaluronan Studies
por: Wang, Wei, et al.
Publicado: (2012)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ipupt62j0ps3httd4ng7rsdtl2